Danielle Crawley

666 total citations
33 papers, 381 citations indexed

About

Danielle Crawley is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Danielle Crawley has authored 33 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Danielle Crawley's work include Prostate Cancer Treatment and Research (16 papers), Metabolism, Diabetes, and Cancer (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Danielle Crawley is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Metabolism, Diabetes, and Cancer (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Danielle Crawley collaborates with scholars based in United Kingdom, Sweden and United States. Danielle Crawley's co-authors include Mieke Van Hemelrijck, Jan Adolfsson, Sarah Rudman, Cecilia Bosco, Lars Holmberg, Hans Garmo, Pär Stattin, Björn Zethelius, Jennifer Melvin and Simon Chowdhury and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Danielle Crawley

30 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Crawley United Kingdom 12 146 142 117 112 70 33 381
Julie Huang United States 10 106 0.7× 114 0.8× 91 0.8× 57 0.5× 28 0.4× 19 435
Heather Beckwith United States 11 58 0.4× 95 0.7× 151 1.3× 180 1.6× 50 0.7× 22 365
Alessandro De Luca Italy 13 70 0.5× 74 0.5× 126 1.1× 200 1.8× 38 0.5× 46 521
L. Brureau France 15 342 2.3× 104 0.7× 99 0.8× 102 0.9× 34 0.5× 55 535
Mari‐Anne Rowlands United Kingdom 8 130 0.9× 146 1.0× 88 0.8× 119 1.1× 147 2.1× 9 394
J.M. Cózar Spain 14 351 2.4× 118 0.8× 88 0.8× 224 2.0× 66 0.9× 67 773
Franklin Gaylis United States 12 281 1.9× 96 0.7× 96 0.8× 102 0.9× 86 1.2× 38 506
P. Stattin Sweden 7 257 1.8× 186 1.3× 160 1.4× 184 1.6× 66 0.9× 17 512
Norman G. Nicolson United States 11 52 0.4× 67 0.5× 60 0.5× 130 1.2× 121 1.7× 24 332
Kris E. Gaston United States 12 285 2.0× 98 0.7× 65 0.6× 116 1.0× 50 0.7× 44 573

Countries citing papers authored by Danielle Crawley

Since Specialization
Citations

This map shows the geographic impact of Danielle Crawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Crawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Crawley more than expected).

Fields of papers citing papers by Danielle Crawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Crawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Crawley. The network helps show where Danielle Crawley may publish in the future.

Co-authorship network of co-authors of Danielle Crawley

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Crawley. A scholar is included among the top collaborators of Danielle Crawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Crawley. Danielle Crawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Daniel, Andrea Billè, Akshay J. Patel, et al.. (2025). A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA). Clinical Lung Cancer. 26(3). e223–e231. 1 indexed citations
2.
3.
4.
Hussain, Sufyan, et al.. (2023). Presentation of new onset type 1 diabetes with diabetic ketoacidosis and hyperosmolar hyperglycaemia after a single dose of nivolumab and ipilimumab. Endocrinology Diabetes and Metabolism Case Reports. 2023(3). 1 indexed citations
5.
Beckmann, Kerri, Danielle Crawley, William G. Nelson, et al.. (2022). Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer. Cancer Causes & Control. 33(3). 429–440. 4 indexed citations
6.
Garmo, Hans, Emil Hagström, Mieke Van Hemelrijck, et al.. (2022). Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden. British Journal of Cancer. 128(5). 814–824. 3 indexed citations
7.
Goode, E., Danielle Crawley, Charlotte Moss, et al.. (2020). 243P UK experience of the management of pregnancy associated breast cancer: A national retrospective review of practice. Annals of Oncology. 31. S337–S337.
8.
Crawley, Danielle, Ronan Breen, Paul Elkington, & Eleni Karapanagiotou. (2020). Tuberculosis associated with Triplet therapy for lung cancer. Thorax. 75(7). 609–610. 6 indexed citations
9.
Parker, Jonathan, Danielle Crawley, Hans Garmo, et al.. (2020). Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study. Frontiers in Oncology. 10. 571838–571838. 4 indexed citations
10.
Crawley, Danielle, Kerri Beckmann, Debra H. Josephs, et al.. (2020). Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.. Journal of Clinical Oncology. 38(15_suppl). e21625–e21625. 1 indexed citations
11.
Crawley, Danielle, Eleni Karapanagiotou, Scott N. Holden, et al.. (2020). Psychological experiences in patients with lung cancer taking targeted therapies. Lung Cancer. 139. S82–S83. 1 indexed citations
12.
Crawley, Danielle, Hans Garmo, Sarah Rudman, et al.. (2018). Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study. BMJ Open. 8(3). e020787–e020787. 7 indexed citations
13.
Crawley, Danielle, Florence Chamberlain, Hans Garmo, et al.. (2018). A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus. ecancermedicalscience. 12. 802–802. 24 indexed citations
14.
Crawley, Danielle, Ashish Chandra, Massimo Loda, et al.. (2017). Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer. BMC Cancer. 17(1). 494–494. 17 indexed citations
15.
Crawley, Danielle, Massimo Loda, Cheryl Gillett, et al.. (2016). Metformin and longevity (METAL): A window of opportunity study investigating the biological effects of metformin in localised prostate cancer. Annals of Oncology. 27. vi261–vi261. 2 indexed citations
16.
Hemelrijck, Mieke Van, et al.. (2016). Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy. World Journal of Urology. 35(1). 35–43. 10 indexed citations
17.
Crawley, Danielle, Lars Holmberg, Jennifer Melvin, et al.. (2014). Serum glucose and risk of cancer: a meta-analysis. BMC Cancer. 14(1). 985–985. 31 indexed citations
18.
Crawley, Danielle, Cecilia Bosco, Jennifer Melvin, et al.. (2014). Obesity and cancer: the role of vitamin D. BMC Cancer. 14(1). 712–712. 30 indexed citations
19.
Pennycuick, Adam, Thomas Simpson, Danielle Crawley, et al.. (2012). Routine EGFR and KRAS Mutation analysis using COLD-PCR in non-small cell lung cancer. International Journal of Clinical Practice. 66(8). 748–752. 16 indexed citations
20.
Politou, Marianna, Kikkeri N. Naresh, Evangelos Terpos, et al.. (2005). Anti-Angiogenic Effect of Bortezomib in Patients with Multiple Myeloma. Acta Haematologica. 114(3). 170–173. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Huang Breakdown of academic impact, for papers by Heather Beckwith Breakdown of academic impact, for papers by Alessandro De Luca Breakdown of academic impact, for papers by L. Brureau Breakdown of academic impact, for papers by Mari‐Anne Rowlands Breakdown of academic impact, for papers by J.M. Cózar Breakdown of academic impact, for papers by Franklin Gaylis Breakdown of academic impact, for papers by P. Stattin Breakdown of academic impact, for papers by Norman G. Nicolson Breakdown of academic impact, for papers by Kris E. Gaston
Rankless by CCL
2026